These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32103595)
21. Differentiation of benign from malignant nodules by accumulation of Tc-99m pertechnetate using TI-201 delayed scans. Okumura Y; Takeda Y; Sato S; Shimizu M; Komatsu M; Honda O; Nakagawa T; Niiya H; Hiraki Y Clin Nucl Med; 1998 Aug; 23(8):514-6. PubMed ID: 9712383 [TBL] [Abstract][Full Text] [Related]
22. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology. Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385 [TBL] [Abstract][Full Text] [Related]
23. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. Földes I; Lévay A; Stotz G Eur J Nucl Med; 1993 Apr; 20(4):330-3. PubMed ID: 8387921 [TBL] [Abstract][Full Text] [Related]
24. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124 [TBL] [Abstract][Full Text] [Related]
25. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Giovanella L; Suriano S; Maffioli M; Ceriani L; Spriano G Head Neck; 2010 May; 32(5):607-11. PubMed ID: 19693945 [TBL] [Abstract][Full Text] [Related]
26. Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjögren syndrome: evaluation using salivary gland scintigraphy. Taura S; Murata Y; Aung W; Ishida R; Zhang L; Hossain M; Takahashi Y; Okada N; Shibuya H Clin Nucl Med; 2002 Apr; 27(4):265-9. PubMed ID: 11914666 [TBL] [Abstract][Full Text] [Related]
27. Usefulness of 99mTc-pertechnetate scintigraphy and fine-needle aspiration cytology in patients with solitary thyroid nodules and thyroid cancer. Lumachi F; Varotto L; Borsato S; Tregnaghi A; Zucchetta P; Marzola MC; Cecchin D; Bui F Anticancer Res; 2004; 24(4):2531-4. PubMed ID: 15330209 [TBL] [Abstract][Full Text] [Related]
28. Validity of dual tracer 99mTc-tetrofosmin and 99mTc-pertechnetate subtraction parathyroid scintigraphy in patients with primary and secondary hyperparathyroidism. Dugonjić S; Ajdinović B; Cerović S; Janković Z Vojnosanit Pregl; 2009 Dec; 66(12):949-53. PubMed ID: 20095513 [TBL] [Abstract][Full Text] [Related]
29. The use of dual phase 201Tl thyroid scan for equivocal fine-needle aspiration results in cold thyroid nodules. Lin CC; Sun SS; Yang MD; Kao A; Lee CC Anticancer Res; 2001; 21(4B):2969-72. PubMed ID: 11712795 [TBL] [Abstract][Full Text] [Related]
30. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis. Hiromatsu Y; Ishibashi M; Miyake I; Nonaka K Eur J Nucl Med; 1998 Oct; 25(10):1448-52. PubMed ID: 9818287 [TBL] [Abstract][Full Text] [Related]
31. The additional diagnostic value of a single-session combined scintigraphic and ultrasonographic examination in patients with thyroid and parathyroid diseases. Gedik GK; Bozkurt FM; Ugur O; Grassetto G; Rubello D Panminerva Med; 2008 Sep; 50(3):199-205. PubMed ID: 18927523 [TBL] [Abstract][Full Text] [Related]
32. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group. Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning. Wei JP; Burke GJ Ann Surg Oncol; 1995 May; 2(3):233-7. PubMed ID: 7641020 [TBL] [Abstract][Full Text] [Related]
34. Comparing dual phase Tl-201 thyroid scan and fine-needle aspiration cytology to detect follicular carcinoma. Leung HC; Chang CT; Wu HS; Wang TY; Sun SS; Kao CH Endocr Res; 2003 Aug; 29(3):291-7. PubMed ID: 14535630 [TBL] [Abstract][Full Text] [Related]
35. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing. Powell DK; Nwoke F; Goldfarb RC; Ongseng F Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932 [TBL] [Abstract][Full Text] [Related]
36. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430 [TBL] [Abstract][Full Text] [Related]
37. Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute tc-99m MIBI scans. Sharma R; Mondal A; Shankar LR; Sahoo M; Bhatnagar P; Sawroop K; Chopra MK; Kashyap R Clin Nucl Med; 2004 Sep; 29(9):534-7. PubMed ID: 15311117 [TBL] [Abstract][Full Text] [Related]
38. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging. Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407 [TBL] [Abstract][Full Text] [Related]
39. [99m-Technetium-pertechnetate- and 99m-Technetium-sestamibi-scintigraphy for visualization of hypofunctioning thyroid tissue and staging in a dog with thyroid carcinoma]. Altmann H; Cui Y; Henrich M; Schaub S; Thiel C; Moritz A; Bauer R; Bauer N Tierarztl Prax Ausg K Kleintiere Heimtiere; 2022 Dec; 50(6):446-456. PubMed ID: 36516844 [TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]